Neok Bio

Palo Alto, United States

Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.

$75.0M raised

Nov 2025

Series A

Top Investors

ABL Bio

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neok Bio raised?

Neok Bio has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in November 2025.

Who are Neok Bio's investors?

Neok Bio's investors include ABL Bio.

Where is Neok Bio headquartered?

Neok Bio is headquartered in Palo Alto, United States.

What does Neok Bio do?

Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.

What stage is Neok Bio at?

Neok Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 4, 2025.

MLA

"Neok Bio — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/neok-bio. Accessed June 17, 2026.

APA

VCBacked. (2025). Neok Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/neok-bio

Wikipedia (cite web)

{{cite web |title=Neok Bio — Funding & Investors |url=https://www.vcbacked.co/company/neok-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 4, 2025.